Guinea Pig Gut Contains Multiple Opioid Peptides That Control Motility
The nerve network controlling gut movement contains more proenkephalin-derived peptides than prodynorphin-derived ones, with met-enkephalin being the dominant form.
Quick Facts
What This Study Found
The myenteric plexus (the nerve network that controls gut movement) of guinea pig small intestine contained a well-defined mix of opioid peptides.
Met-enkephalin dominated at 405 pmol/g of tissue. Three other enkephalin-related peptides were present at 90 to 100 pmol/g each. Two rarer enkephalin forms (BAM-18 and Met-enkephalyl-Arg-Arg-Val-NH2) were present at 24 and 5 pmol/g.
Dynorphin-family peptides (alpha-neoendorphin, beta-neoendorphin, dynorphin A(1-8), and dynorphin B) were all present at 12 to 15 pmol/g. Full-length dynorphin A was very scarce at only 0.8 pmol/g.
No beta-endorphin was detected.
The two rare enkephalin forms (BAM-18 and MERV-NH2) had an unusual receptor profile: they preferred mu and kappa opioid receptors rather than the delta receptors that most enkephalins favor. This means they may have different functional roles in the gut.
Key Numbers
How They Did This
Two-step HPLC separation followed by bioassay on mouse vas deferens tissue, with naloxone confirmation of opioid specificity. Guinea pig small intestine myenteric plexus tissue was extracted and analyzed. Receptor binding profiles were determined for each peptide.
Why This Research Matters
This was the most complete map of opioid peptides in gut nerve tissue at its time. The dominance of enkephalins over dynorphins, and the absence of endorphin, shows the gut's opioid system has a very different composition than the brain. The unusual receptor profiles of rare enkephalins suggest specialized roles in gut regulation.
The Bigger Picture
Understanding which opioid peptides control gut motility is essential for developing targeted treatments for constipation, diarrhea, and irritable bowel syndrome.
What This Study Doesn't Tell Us
Tested in guinea pig tissue only. Human gut opioid peptide profiles may differ. The bioassay method measures activity rather than exact mass. Only one segment of the small intestine was analyzed.
Questions This Raises
- ?Can selective enkephalin receptor drugs treat gut motility disorders?
- ?Does the opioid peptide profile change in disease states?
Trust & Context
- Key Stat:
- Met-enkephalin dominates In the nerve network that controls gut movement
- Evidence Grade:
- Preliminary in-vitro study with rigorous HPLC-bioassay methodology in a single species.
- Study Age:
- Published in 1988 — baseline characterization of gut opioid peptides.
- Original Title:
- Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.
- Published In:
- Journal of neurochemistry, 51(1), 32-7 (1988)
- Authors:
- Corbett, A D(2), McKnight, A T, Kosterlitz, H W(3)
- Database ID:
- RPEP-00067
Evidence Hierarchy
Frequently Asked Questions
What is the myenteric plexus?
A network of nerves sandwiched between the muscle layers of the gut wall. It controls gut contractions and is sometimes called the "gut brain" or second nervous system.
Why is met-enkephalin important in the gut?
As the dominant gut opioid, met-enkephalin is a key regulator of motility, fluid secretion, and pain sensation in the intestines.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00067APA
Corbett, A D; McKnight, A T; Kosterlitz, H W. (1988). Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.. Journal of neurochemistry, 51(1), 32-7.
MLA
Corbett, A D, et al. "Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.." Journal of neurochemistry, 1988.
RethinkPeptides
RethinkPeptides Research Database. "Tissue content of opioid peptides in the myenteric plexus-lo..." RPEP-00067. Retrieved from https://rethinkpeptides.com/research/corbett-1988-tissue-content-of-opioid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.